181 related articles for article (PubMed ID: 9652505)
1. Classification of bone tumors.
Bertoni F; Bacchini P
Eur J Radiol; 1998 May; 27 Suppl 1():S74-6. PubMed ID: 9652505
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of cartilaginous tumors: a retrospective study of 79 patients.
De Beuckeleer LH; De Schepper AM; Ramon F; Somville J
Eur J Radiol; 1995 Nov; 21(1):34-40. PubMed ID: 8654456
[TBL] [Abstract][Full Text] [Related]
3. [Cartilaginous tumors of the skeleton].
Meffert O; Peiper HJ
Chirurg; 1976 Jul; 47(7):392-9. PubMed ID: 954515
[TBL] [Abstract][Full Text] [Related]
4. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
5. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton--biochemistry and cell biology of chondrosarcoma and its variants.
Aigner T
Virchows Arch; 2002 Sep; 441(3):219-30. PubMed ID: 12242518
[TBL] [Abstract][Full Text] [Related]
6. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
[TBL] [Abstract][Full Text] [Related]
7. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
9. Cytopathology of chondromyxoid fibroma: a case series and review of the literature.
Wangsiricharoen S; Wakely PE; Siddiqui MT; Ali SZ
J Am Soc Cytopathol; 2021; 10(4):366-381. PubMed ID: 33958292
[TBL] [Abstract][Full Text] [Related]
10. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
Jiang L; Liu J; Wei Q; Wang Y
Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
[TBL] [Abstract][Full Text] [Related]
11. [Pathomorphology of malignant chondrogenic bone tumors--an analysis of 94 cases from the Hamburg Bone Tumor Register (1974-1989)].
Delling G; Welkerling H
Z Orthop Ihre Grenzgeb; 1992; 130(1):1-8. PubMed ID: 1532267
[TBL] [Abstract][Full Text] [Related]
12. [Cartilage tumors of the skeleton].
Jundt G; Baumhoer D
Pathologe; 2008 Nov; 29 Suppl 2():223-31. PubMed ID: 18820927
[TBL] [Abstract][Full Text] [Related]
13. What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas?
Douis H; Parry M; Vaiyapuri S; Davies AM
Eur Radiol; 2018 Jan; 28(1):398-409. PubMed ID: 28695356
[TBL] [Abstract][Full Text] [Related]
14. ERG expression in chondrogenic bone and soft tissue tumours.
Shon W; Folpe AL; Fritchie KJ
J Clin Pathol; 2015 Feb; 68(2):125-9. PubMed ID: 25378537
[TBL] [Abstract][Full Text] [Related]
15. [Histologic grading of chondrosarcoma. A qualitative and quantitative analysis of 74 cases of the Hamburg bone tumor register].
Welkerling H; Werner M; Delling G
Pathologe; 1996 Jan; 17(1):18-25. PubMed ID: 8685092
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage.
Okajima K; Honda I; Kitagawa T
Cancer; 1988 Feb; 61(4):792-9. PubMed ID: 3276387
[TBL] [Abstract][Full Text] [Related]
18. Malignant tumors of the osteogenic matrix.
Spina V; Montanari N; Romagnoli R
Eur J Radiol; 1998 May; 27 Suppl 1():S98-109. PubMed ID: 9652509
[TBL] [Abstract][Full Text] [Related]
19. Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma.
Salas S; de Pinieux G; Gomez-Brouchet A; Larrousserie F; Leroy X; Aubert S; Decouvelaere AV; Giorgi R; Fernandez C; Bouvier C
Virchows Arch; 2009 Jan; 454(1):81-7. PubMed ID: 19050913
[TBL] [Abstract][Full Text] [Related]
20. [Cytogenesis and histogenesis of malignant and semimalignant bone tumors].
Roessner A; Grundmann E
Veroff Pathol; 1984; 122():1-195. PubMed ID: 6091360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
